Dr. Claudia Santelices
Overview of key social and behavioral issues related to substance use.
Qualitative Research:
Answers "Why?" questions.
Utilizes observation, symbols, words, etc.
Involves non-statistical analysis and interpretation of data.
Quantitative Research:
Answers "How many?" or "How much?" questions.
Involves statistical analysis and numerical data.
Mary Jane Schneider's quote emphasizing the need for public health awareness among citizens.
Substance Use Disorder (SUD):
Symptoms include tolerance and withdrawal.
Behavioral changes due to biochemical changes in the brain.
Prioritization of substance use over personal and others' harm.
Classified now as the medical term for addiction by the APA, replacing "substance abuse" and "substance dependence."
First Wave:
Opioid pill overdoses began rising in 2000 and continued to 2016.
Second Wave:
Increase in heroin overdoses starting in 2007, surpassing opioid pills in 2015.
Third Wave:
Fentanyl and synthetic opioids emerge dramatically after 2013, now over 95% of opioid overdoses linked to fentanyl.
Rates tripled in the U.S. from 1999 to 2018 with synthetic opioids as main contributors.
Fentanyl-related overdose rates increased 33-fold from 1999 to 2018.
Data from CDC in December 2020 indicates rising fatal drug overdoses during the COVID-19 pandemic.
Massachusetts data: Opioid mortality quintupled from 2000 to 2019 with increased fentanyl presence.
SUDs linked with broader issues:
Rising healthcare costs, AIDS epidemic, racial disparities, and violent crime.
Focus on injection practices, syringe acquisition, and discard behaviors among Injecting Drug Users (IDUs).
Integration of epidemiological, ethnographic, and bioassay methods to identify HIV-1 and hepatitis risk factors.
Recruitment of IDUs through outreach, surveys, and statistical analysis of health trends.
Demographic breakdown of male and racial demographics across Hartford, New Haven, and Springfield.
Self-reported health conditions among IDUs in different cities detailing rates of HIV, hepatitis, TB, and mental illness.
Exploring neighborhood variations and drug injection practices.
Development of tailored prevention programs.
In-depth ethnographic descriptions, focus groups, interviews, and mapping of drug use environments.
Analyze how environment shapes drug use and associated risks.
Community mapping of drug-related locations to inform risk factors.
Focus on daily interactions with drug use, capturing both patterns and emotional responses.
Provide insights into HIV and hepatitis risks, allowing for real-time reflections on behaviors.
Personal accounts can motivate change among users.
Documenting crises and emotional turmoil associated with drug use.
Ethnographic observations focusing on IDU interactions and behaviors in their environment.
Guidelines for systematically observing drug injection practices to assess various risks.
Emphasis on harm reduction strategies including syringe exchange programs and safe injection sites.
Addressing methodological, legal, and health-related challenges in conducting research in high-risk populations.
Enhance ethnographic methods for deeper understanding and intervention strategies.